These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


711 related items for PubMed ID: 11097963

  • 1. Imipramine and buspirone in treatment of patients with generalized anxiety disorder who are discontinuing long-term benzodiazepine therapy.
    Rickels K, DeMartinis N, García-España F, Greenblatt DJ, Mandos LA, Rynn M.
    Am J Psychiatry; 2000 Dec; 157(12):1973-9. PubMed ID: 11097963
    [Abstract] [Full Text] [Related]

  • 2. Imipramine and buspirone in patients with panic disorder who are discontinuing long-term benzodiazepine therapy.
    Rynn M, García-España F, Greenblatt DJ, Mandos LA, Schweizer E, Rickels K.
    J Clin Psychopharmacol; 2003 Oct; 23(5):505-8. PubMed ID: 14520129
    [Abstract] [Full Text] [Related]

  • 3. Is imipramine or buspirone treatment effective in patients wishing to discontinue long-term benzodiazepine use?
    Sontheimer DL, Ables AZ.
    J Fam Pract; 2001 Mar; 50(3):203. PubMed ID: 11252203
    [No Abstract] [Full Text] [Related]

  • 4. Benzodiazepine discontinuation in generalized anxiety disorder.
    Gupta R, Gupta N, Avasthi A.
    Am J Psychiatry; 2002 Feb; 159(2):321-2. PubMed ID: 11823290
    [No Abstract] [Full Text] [Related]

  • 5. Abecarnil for the treatment of generalized anxiety disorder: a placebo-controlled comparison of two dosage ranges of abecarnil and buspirone.
    Pollack MH, Worthington JJ, Manfro GG, Otto MW, Zucker BG.
    J Clin Psychiatry; 1997 Feb; 58 Suppl 11():19-23. PubMed ID: 9363044
    [Abstract] [Full Text] [Related]

  • 6. [Efficacy and withdrawal of clobazam, lorazepam and buspirone in the treatment of anxiety disorders].
    Lemoine P, Rouillon F, Pouget D.
    Encephale; 1996 Feb; 22(6):461-7. PubMed ID: 10901839
    [Abstract] [Full Text] [Related]

  • 7. Prior benzodiazepine exposure and benzodiazepine treatment outcome.
    Rickels K, Freeman EW.
    J Clin Psychiatry; 2000 Jun; 61(6):409-13. PubMed ID: 10901337
    [Abstract] [Full Text] [Related]

  • 8. Comparative efficacy of alprazolam, imipramine, and placebo administered once a day in treating depressed patients.
    Mendels J, Schless AP.
    J Clin Psychiatry; 1986 Jul; 47(7):357-61. PubMed ID: 2873131
    [Abstract] [Full Text] [Related]

  • 9. Long-term therapeutic use of benzodiazepines. I. Effects of abrupt discontinuation.
    Rickels K, Schweizer E, Case WG, Greenblatt DJ.
    Arch Gen Psychiatry; 1990 Oct; 47(10):899-907. PubMed ID: 2222129
    [Abstract] [Full Text] [Related]

  • 10. A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group.
    Lydiard RB, Ballenger JC, Rickels K.
    J Clin Psychiatry; 1997 Oct; 58 Suppl 11():11-8. PubMed ID: 9363043
    [Abstract] [Full Text] [Related]

  • 11. Prior benzodiazepine use and buspirone response in the treatment of generalized anxiety disorder.
    DeMartinis N, Rynn M, Rickels K, Mandos L.
    J Clin Psychiatry; 2000 Feb; 61(2):91-4. PubMed ID: 10732655
    [Abstract] [Full Text] [Related]

  • 12. Long-term benzodiazepine users 3 years after participation in a discontinuation program.
    Rickels K, Case WG, Schweizer E, Garcia-Espana F, Fridman R.
    Am J Psychiatry; 1991 Jun; 148(6):757-61. PubMed ID: 2035717
    [Abstract] [Full Text] [Related]

  • 13. Buspirone and imipramine for the treatment of major depression in the elderly.
    Schweizer E, Rickels K, Hassman H, Garcia-España F.
    J Clin Psychiatry; 1998 Apr; 59(4):175-83. PubMed ID: 9590668
    [Abstract] [Full Text] [Related]

  • 14. Low-sedation potential of buspirone compared with alprazolam and lorazepam in the treatment of anxious patients: a double-blind study.
    Cohn JB, Wilcox CS.
    J Clin Psychiatry; 1986 Aug; 47(8):409-12. PubMed ID: 2874128
    [Abstract] [Full Text] [Related]

  • 15. Switching from benzodiazepines to buspirone using a tapered overlap method in generalized anxiety disorder.
    Arató M.
    J Clin Psychiatry; 2001 Aug; 62(8):657-8. PubMed ID: 11561943
    [No Abstract] [Full Text] [Related]

  • 16. Concurrent use of buspirone in anxious patients during withdrawal from alprazolam therapy.
    Udelman HD, Udelman DL.
    J Clin Psychiatry; 1990 Sep; 51 Suppl():46-50. PubMed ID: 2211568
    [Abstract] [Full Text] [Related]

  • 17. Buspirone and lorazepam in the treatment of generalized anxiety disorder in outpatients.
    Laakmann G, Schüle C, Lorkowski G, Baghai T, Kuhn K, Ehrentraut S.
    Psychopharmacology (Berl); 1998 Apr; 136(4):357-66. PubMed ID: 9600581
    [Abstract] [Full Text] [Related]

  • 18. Assessment of the efficacy of buspirone in patients affected by generalized anxiety disorder, shifting to buspirone from prior treatment with lorazepam: a placebo-controlled, double-blind study.
    Delle Chiaie R, Pancheri P, Casacchia M, Stratta P, Kotzalidis GD, Zibellini M.
    J Clin Psychopharmacol; 1995 Feb; 15(1):12-9. PubMed ID: 7714222
    [Abstract] [Full Text] [Related]

  • 19. Switching from long-term benzodiazepine therapy to pregabalin in patients with generalized anxiety disorder: a double-blind, placebo-controlled trial.
    Hadley SJ, Mandel FS, Schweizer E.
    J Psychopharmacol; 2012 Apr; 26(4):461-70. PubMed ID: 21693549
    [Abstract] [Full Text] [Related]

  • 20. Comparison of withdrawal of buspirone and diazepam: a placebo controlled study.
    Fontaine R, Beaudry P, Beauclair L, Chouinard G.
    Prog Neuropsychopharmacol Biol Psychiatry; 1987 Apr; 11(2-3):189-97. PubMed ID: 2888159
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 36.